Cargando…
Psychiatric Drug Development: Diagnosing a Crisis
Although one in five Americans currently takes at least one psychiatric drug and mental disorders are recognized worldwide, global pharmaceutical industry funding for new, innovative medications is in serious decline despite promising advances in genetics. The author traces the evolution of psychiat...
Autor principal: | Hyman, Steven E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Dana Foundation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662213/ https://www.ncbi.nlm.nih.gov/pubmed/23720708 |
Ejemplares similares
-
Diagnosing the DSM: Diagnostic Classification Needs Fundamental Reform
por: Hyman, Steven E.
Publicado: (2011) -
Psychiatric Crisis Care and the More is Less Paradox
por: Drake, Robert E., et al.
Publicado: (2021) -
Intensive home treatment for adolescents in psychiatric crisis
por: Muskens, Jet B., et al.
Publicado: (2019) -
Are Psychiatric Diagnoses an Obstacle for Research and Practice? Reliability, Validity and the Problem of Psychiatric Diagnoses. The Case of GAD
por: Faravelli, Carlo, et al.
Publicado: (2012) -
Psychiatric and non-psychiatric population vulnerabilities in time of a crisis: the unsuspected aggression factor
por: Martin, Sylvia, et al.
Publicado: (2023)